Anivance AI Heads to MEDICA 2024 in Germany

Anivance AI is a leader in organ-on-chip technology, specializing in high-precision organ chip solutions and intelligent image analysis platforms for drug development, toxicity testing, and cell therapy research.

Our core products encompass organ chips for the lung and liver, integrated with automated data analysis systems that accurately simulate human physiological environments, providing real-time, reliable testing data. 

Anivance AI serves clients worldwide, helping to reduce screening cycles, lower development costs, and enhance R&D accuracy.